Request More Information
Closex
Requesting information on Prohaler® Multi-dose Dry Powder Inhaler.
Prohaler® is a high performance, multi-dose dry powder inhaler (DPI) that helps to improve patient compliance and adherence in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is activated by simply breathing. It’s lightweight and intuitive design is easy to use and suitable for all patient types.




We understand the challenges that asthma and COPD patients face in managing their conditions and maintaining compliance with their treatment regimens. When our dedicated teams of inhalation R&D scientists worked with international thought leaders and patients, their goal was to design and deliver a simple, reliable and intuitive multi-dose dry powder inhaler (DPI) system that would enhance patient compliance and adherence.
We made the device lightweight and portable so that it’s really easy to use. Dose indication and acknowledgement are an integrated part of the design to provide patients with confidence to self-manage their treatment. We designed Prohaler® using the QbD (Quality by Design) approach and this allowed us to ensure that the product meets the desired performance standards, is safe and reliable, and is easy to use by patients. Additionally, the use of QbD enabled us to minimize the risk of product failure and maximize the likelihood of success.
With only three simple steps to operate: Open, Breathe-in, Close (OBIC) practically all patients can use Prohaler®.
Prohaler® is lightweight and portable and intuitive to use so it can always stay with the patient. It carries up to 30 individual powder doses in separate sealed laminated blisters for optimal moisture protection.
With an integrated visual dose indicator, the user knows if there are doses remaining in the device. Prohaler® also incorporates an audible click noise when the dry powder dose is administered so the user can easily confirm dosing success.
With its unique breath-triggered blister opening mechanism, Prohaler® reduces dose wastage, which can be a common problem with other conventional DPIs.
We are a trusted authority and leading company for the latest innovations in inhalation and dry powder inhaled drug delivery. This is based on our decades long experience in this specialized drug delivery route. Aptar Pharma offers comprehensive development and support services to help our customers derisk and accelerate the process of bringing these important respiratory products to the patients that need them most.
Our extensive knowledge of dry powder inhalation products, our broad range of specialized formulation development, analytical development, technical and regulatory support can help guide customers through the challenging and constantly evolving regulatory approval landscape. Aptar Pharma is your ideal partner for new or repositioned multi-dose DPI products.
Contact us now and benefit from our proven know-how in innovative inhalation solutions.



